Infectious Diseases News and Research

RSS

Children born to women on HIV therapy more likely to have microcephaly, developmental delays

Children born to women on HIV therapy containing the drug efavirenz were 2 to 2.5 times more likely to have microcephaly, or small head size, compared to children born to women on regimens of other antiretroviral drugs, according to an analysis funded by the National Institutes of Health.

18 Nov 2019

'Dysbiosis' promotes the onset of colorectal cancer

The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti - holder of the Microbiology and Infectious Diseases Chair at the Collège de France -, have demonstrated that an imbalance in the gut microbiota, also known as "dysbiosis", promotes the onset of colorectal cancer.

18 Nov 2019

BGU researchers discover gene that causes nighttime atrial fibrillation

Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).

18 Nov 2019

New CDC report raises concern over growing threat of antibiotic resistance

In the US, antibiotic-resistant germs are making millions sick and killing tens of thousands, according to new CDC report.

18 Nov 2019

New clinical guideline for treatment of drug-resistant tuberculosis published

The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society and the Infectious Diseases Society of America have published an official clinical guideline on the treatment of drug-resistant tuberculosis in the Nov. 15 American Journal of Respiratory and Critical Care Medicine.

18 Nov 2019

New NIH funding will accelerate progress in TB vaccine development

Seattle Children's Research Institute is one of three recipients of $30 million in first-year-funding provided by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to establish centers for immunology research to accelerate progress in tuberculosis vaccine development.

15 Nov 2019

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

15 Nov 2019

Study provides new insights into potential outcomes of Zika virus infection

Using a relevant animal model (pigs), University of Saskatchewan researchers have shown that mild Zika virus infection in fetuses can cause abnormal brain development in apparently healthy young animals.

15 Nov 2019

Access to mobile phone location data can help understand spread of vector-borne diseases

Researchers from EPFL and MIT have shown that human mobility is a major factor in the spread of vector-borne diseases such as malaria and dengue even over short intra-city distances. In a paper published in Scientific Reports, the team compares different mobility models and concludes that having access to mobile phone location data can prove crucial in understanding disease transmission dynamics - and, ultimately, in stopping an outbreak from evolving into an epidemic.

15 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

14 Nov 2019

Study sheds light on how HIV infection may increase risk for sudden cardiac death

The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death.

14 Nov 2019

Russian scientists explain how an additional component can triple vaccine efficiency

A team of Russian scientists carried out a study on the cell immunity level and found out how an adjuvant called azoximer bromide increases the immunogenicity of the anti-flu vaccine.

12 Nov 2019

New study sounds a note of caution in using probiotics in ICU

It's become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in using probiotics proactively in the ICU. A large multicenter clinical trial in Canada is testing whether probiotics would prevent ventilator-associated pneumonia in adult ICU patients.

12 Nov 2019

Vaccine decreases chances of severe pneumonia in children

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

12 Nov 2019

Researchers generate reliable maps for transmission risk of Zika virus

The spread of infectious diseases such as Zika depends on many different factors. Environmental factors play a role, as do socioeconomic factors. Recently, several attempts have be made to predict the transmission risk of the Zika virus at a global and local level, but the spatial and temporal patterns of transmission are still not well understood.

11 Nov 2019

Researchers develop new, promising class of active ingredients against resistant bacteria

Researchers at the Martin Luther University Halle-Wittenberg have developed a new, promising class of active ingredients against resistant bacteria.

11 Nov 2019

Study pinpoints new weapon to fight against deadly microbes

Researchers at Monash University have gained insights into how nanoparticles could be used to identify the presence of invasive and sometimes deadly microbes, and deliver targeted treatments more effectively.

10 Nov 2019

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

10 Nov 2019

Illinois researchers develop lab-on-a-smartphone system to detect infectious diseases

Infectious diseases such as Zika and Dengue remain a top contributor to death and disability across the globe, according to the World Health Organization.

10 Nov 2019

Infectious Diseases News and Research

Children born to women on HIV therapy more likely to have microcephaly, developmental delays

'Dysbiosis' promotes the onset of colorectal cancer

BGU researchers discover gene that causes nighttime atrial fibrillation

New CDC report raises concern over growing threat of antibiotic resistance

New clinical guideline for treatment of drug-resistant tuberculosis published

New NIH funding will accelerate progress in TB vaccine development

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

Study provides new insights into potential outcomes of Zika virus infection

Access to mobile phone location data can help understand spread of vector-borne diseases

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

Study sheds light on how HIV infection may increase risk for sudden cardiac death

Russian scientists explain how an additional component can triple vaccine efficiency

New study sounds a note of caution in using probiotics in ICU

Vaccine decreases chances of severe pneumonia in children

Researchers generate reliable maps for transmission risk of Zika virus

Researchers develop new, promising class of active ingredients against resistant bacteria

Study pinpoints new weapon to fight against deadly microbes

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Illinois researchers develop lab-on-a-smartphone system to detect infectious diseases

eBook: Advancing infectious disease vaccine development eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News